Related Experiment Video
Updated: Jul 25, 2026

Echocardiographic Evaluation of Atrial Communications before Transcatheter Closure
Published on: February 8, 2022
The association between patent foramen ovale and unexplained syncope in pediatric patients
Runmei Zou1, Shuo Wang2, Ping Liu1
1Department of Pediatric Cardiovasology, Children's Medical Center, The Second Xiangya Hospital, Central South University, No.139 Renmin Middle Road, Changsha, Hunan, 410011, China.
Insights
Patent foramen ovale (PFO) may not increase syncope risk in children. This study found no significant association between PFO and syncope in pediatric patients, suggesting further research is needed.
Area of Science:
- Cardiology
- Pediatric Neurology
- Clinical Medicine
Background:
- Patent foramen ovale (PFO) is linked to stroke and syncope in adults.
- PFO closure reduces recurrent cerebral events and syncope in adults.
- The association between PFO and syncope in pediatric patients remains uninvestigated.
Purpose of the Study:
- To investigate the association between patent foramen ovale (PFO) and unexplained syncope in pediatric patients.
- To determine if PFO increases the risk of syncope in children.
Main Methods:
- Retrospective analysis of 1001 pediatric patients (4-17 years) hospitalized for unexplained syncope, headache, dizziness, chest pain, or palpitation.
- Exclusion of children with known causes of syncope or other systemic diseases.
- Transthoracic echocardiography and contrast echocardiography to detect PFO and right-to-left shunting.
Main Results:
- No significant difference in PFO incidence across syncope, headache/dizziness, chest pain, and palpitation groups (4.71%–6.17%).
- Multivariate logistic regression indicated PFO is not associated with an increased risk of syncope (P=0.081).
Conclusions:
- Patent foramen ovale (PFO) may not be a significant risk factor for syncope in pediatric patients.
- Further large-scale, multicenter studies are warranted to confirm the association between PFO and unexplained pediatric syncope.
Background:
Patent foramen ovale (PFO) is associated with transient ischemia attack (TIA) or stroke, paradoxical embolism, and migraines. PFO closure decreases the recurrent incidence of cerebral ischemic events and reduces the incidence of syncope in adults. However, whether PFO is associated with syncope in pediatric patients has not been investigated.
Methods:
1001 pediatric patients (aged 4 to 17 years, mean age 10.31 ± 2.61 years, 519 males) who complained of unexplained syncope, palpitation, headache, dizziness and chest pain and were hospitalized in the Syncope Ward, The Second Xiangya Hospital, Central South University between January 2013 and April 2022 were recruited. Children with definite etiology of syncope, neurological, cardiogenic, psychological and other system diseases were excluded. PFO was measured by transthoracic echocardiography and right-heart contrast echocardiography was performed to identify the presence of right-to-left shunting. The demographic data and medical records were retrospectively reviewed and analyzed.
Results:
276 cases were included in the simple syncope group, 379 cases in the headache/dizziness group, 265 cases in the chest pain group, and 81 cases in the palpitation group. The incidence of PFO between the four groups was insignificant (4.71%, 4.74%, 4.15%, 6.17%, respectively, P = 0.903). Multivariate Logistic regression demonstrated that PFO is not associated with the increased risk of syncope (P = 0.081).
Conclusion:
PFO may not increase the risk of syncope in pediatric patients. Further study may include a large and multicenter sample to investigate the association between PFO and unexplained syncope.
Related Concept Videos
Pharmacokinetics in Pediatric Patients: Drug Excretion
Mitral Stenosis II: Clinical features and Diagnostic Tests
Aneurysm II: Clinical Manifestations and Diagnostic Studies
Hemorrhagic Stroke ll: Pathophysiology
Transient Ischemic Attack l: Introduction
Cerebral Edema ll: Pathophysiology

